Novel Fenofibric Acid Prodrugs with Improved Bioavailability
The present invention relates to a novel fenofibric acid prodrug having improved bioavailability. According to the present invention, the fenofibric acid prodrug of the present invention shows higher bioavailability than existing fenofibric acid. Therefore, the fenofibric acid prodrug of the present invention can be developed as an effective therapeutic agent for treating hyperlipemia or the like.COPYRIGHT KIPO 2017
-
Paragraph 0088-0091
(2017/11/04)
COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS
Disclosed herein are novel compositions and methods for treating or preventing a variety of disorders and conditions associated with lipid metabolism. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising one or more fibric acid or statin derivative compositions alone or in combination with one or more lipid altering agents and/or PDE inhibitors.
-
Page/Page column 61-62
(2009/01/23)
More Articles about upstream products of 1094101-40-2